propoxyphene

tripsit

propoxyphene

Verificar en tripsit

tripsit

dextropropoxyphene

Verificar en tripsit

psychonaut

Dextropropoxyphene

Verificar en psychonaut

isomerdesign

Propoxyphene

Verificar en isomerdesign

pubchem

Propoxyphene

Verificar en pubchem

pubchem

Levopropoxyphene

Verificar en pubchem

druglab

Dextropropoxyphène

Verificar en druglab

drugmap

Dextropropoxyphene

Verificar en drugmap

wiki

Levopropoxyphene

Verificar en wiki

wiki

Dextropropoxyphene

Verificar en wiki

SMILES:CCC(=O)OC(CC1=CC=CC=C1)(C1=CC=CC=C1)C(C)CN(C)C

InChI:InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3

InChI key:XLMALTXPSGQGBX-UHFFFAOYSA-N

Sinónimos: 1-Benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate, [S-(R*,S*)]- #,BDBM82269,BENZENEETHANOL, .ALPHA.-((1R)-2-(DIMETHYLAMINO)-1-METHYLETHYL)-.ALPHA.-PHENYL-, 1-PROPANOATE, (.ALPHA.S)-REL-,Proxyvon,[(2S,3R)-4-Dimethylamino-3-methyl-1,2-diphenyl-butan-2-yl]propanoate,Dextropropoxyphen,Levopropoxyphene,Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (alphaS)-,Darvon,(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate,4-Dimethylamino-3-methyl-1,2-diphenyl-2-propoxybutane,EINECS 207-420-5,propoxyphene,Femadol,J5.928E,DEXTROPROPOXYPHENE [MART.],DEXTROPROPOXYPHENE [INN],Dextropropoxyphene [INN:BAN],(+/-)-PROPOXYPHENE,PROPOXYPHENE [VANDF], Destropropossifene [DCIT],Dextropropoxifeno,Dextroproxifeno, Alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester,D07809,DB00647, Dextropropoxifeno [INN-Spanish],Benzeneethanol, .alpha.-[2-(dimethylamino)-1-methylethyl]-.alpha.-phenyl-, propanoate, [S-(R*,S*)]-,CHEMBL1213351,Propoxyphene,SK 65,USAF EL-84,alpha-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate,Q2268608,alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane,Propoxyphene-D5,Darvon (Salt/Mix), Dextropropoxifeno,capadex,DTXSID1023524,CAS_469-62-5, Bulk dextropropoxyphene (non-dosage forms),(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate,Dextropropoxifeno [INN-Spanish], Antalvic,Dolene (Salt/Mix),alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat [German],Propoxyphene-d,[(2S,3R)-4-dimethylamino-3-methyl-1,2-di(phenyl)butan-2-yl] propanoate, Dextropropoxyphenum [INN-Latin],2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), (2S,3R)-,IDS-ND-004(SECT.2),(+)-PROPOXYPHENE, Dextropropoxyphene[INN:BAN],SCHEMBL25405,DEA No. 9273,Erantin (Salt/Mix), (1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate,alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat, Alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat,Doloxene (Salt/Mix),ZINC1530769,Antalvic, D-Propoxyphene, Dextropropoxyphenum, Alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat [German],co-proxamol,Dextroproxifeno [Spanish],Propoxyphene, d-, Femadol,d-Propoxyphene,Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))-,Propoxyphene, dl-,(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate(ester), Dextroproxifeno [Spanish],SK-65, (+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane,Benzeneethanol, .alpha.-[2-(dimethylamino)-1-methylethyl]-.alpha.-phenyl-, propanoate (ester), [S-(R*,S*)]-, Proxyphen,coproxamol,Destropropossifene,Romidon (Salt/Mix), 4-Dimethylamino-3-methyl-1,2-diphenyl-2-propoxybutane, SK 65,Dextropropoxyphenum,Proxagesic,PROPOXYPHENE, (+/-)-, Alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane,Methanol, compd. with (+-)-alpha-(2-dimethylamino)-1-methylethyl-alpha- phenylphenethyl propionate (1:1),alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester,Bulk dextropropoxyphene (non-dosage forms),1-Benzyl-D5-3-dimethylamino-2-methyl-1-phenylpropylpropionate,Propoxyphene, (+)-,(2S,3R)-(+)-4-(DIMETHYLAMINO)-3-METHYL-1,2-DIPHENYL-2-BUTANOL PROPIONATE (ESTER),Dextropropoxyphenum [INN-Latin],PROPOXYPHENE [MI],darvocet,DEXTROPROPOXYPHENE [WHO-DD],alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate,S2F83W92TK,Dextropropoxyphene,Destropropossifene [DCIT], (S)-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propanoate, (+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionyloxybutane,2621-61-6, (D)-PROPOXYPHENE,[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate, Propoxyphene,.alpha.-d-Propoxyphene, Proxagesic,.alpha.-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester,2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate, (+)-,(S)-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propanoate,Propoxypene,(1R,2S)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate,(D)-PROPOXYPHENE,UNII-II2G62OV6F,C07406,469-62-5,Dextropropoxyphene 0.1 mg/ml in Acetonitrile, Alpha-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate,Dextropropoxyphene 1.0 mg/ml in Acetonitrile,Depromic,BENZENEETHANOL, .ALPHA.-((1R)-2-(DIMETHYLAMINO)-1-METHYLETHYL)-.ALPHA.-PHENYL-, 1-PROPANOATE, (.ALPHA.S)-, Destropropossifene,UNII-S2F83W92TK,di-gesic,(+)-alpha-propoxyphene, Levopropoxyphene,II2G62OV6F, Dextropropoxyphen, Dextroproxifeno,Algafan,(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionyloxybutane,CHEBI:51173,(+)-Propoxyphene solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,Doloxen (Salt/Mix),Abalgin (Salt/Mix),PROPOXYPHENE [HSDB],(+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane,Dextropropoxyphene (INN),HSDB 3175, Alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate, [(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate,GTPL7593,

Similitudes

Poder identificar moléculas similares a la que estudiamos puede permitir inferir algunas de sus propiedades. Hay varias formas de medir la similitud entre moléculas, por su estructura, efectos, interacciones farmacológicas, etc. A continuación, puedes encontrar moléculas similares según varios criterios y herramientas que desarrollamos. Para comprender las limitaciones de estas comparaciones, es crucial referirse siempre a la metodología utilizada para medir esas similitudes.Ten en cuenta: Esta información se proporciona únicamente con fines informativos y no debe interpretarse como asesoramiento médico.

Para medir la similitud estructural, utilizamos el método de Mol2vec Mol2Vec, que es una red neuronal que procesa moléculas y las transforma en puntos en el espacio, de modo que las moléculas con subestructuras químicamente relacionadas se transforman en puntos cercanos en el espacio.

Propiedades de la molécula

Utilizando el modelo de KGPT Aprendizaje Profundo, predecimos varias propiedades de la molécula. Las predicciones se agrupan según el conjunto de datos que se utilizó para obtener esas predicciones. Junto con cada predicción, proporcionamos un gráfico que muestra la distribución de los valores predichos en el conjunto de datos de entrenamiento/prueba/validación. Esto da una estimación de la confiabilidad del modelo.

Description: A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment.
Class
TrainValTest
2.88-3.70-1.36
Description: A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs.
p_np
TrainValTest
-2.24-3.290.40
Description: This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds.
CT_TOX
TrainValTest
-0.49-0.78-0.91
FDA_APPROVED
TrainValTest
0.53-1.27-0.50
Description: A dataset that predicts the solubility of molecules in water. Solubility is an essential property influencing bioavailability and the potential formulation of a drug.
logSolubilitylog(mol/L)
-1.09
TrainValTest
Description: This dataset is centered on predicting the free energy when a molecule is dissolved in water. The energy changes can affect molecular interactions in biological systems.
freesolvkcal/mol
-1.23
TrainValTest
Description: A dataset predicting the lipophilicity of molecules. Lipophilicity is a crucial factor affecting the distribution, metabolism, and excretion of drugs in the body.
lipoAlogP
0.79
TrainValTest
Description: This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency.
low
TrainValTest
-0.17-3.50-2.88
high
TrainValTest
0.72-3.55-0.49
27 entries
12 entries
617 entries

Perspectivas avanzadas

En lo siguiente, proporcionamos un análisis más avanzado sobre las interacciones de una molécula con el metabolismo humano, sitios de acoplamiento, etc.

Afinidades

Afinidades de unión con una lista de 61 sitios de acoplamiento predefinidos. Estas afinidades se utilizan para calcular las similitudes de interacciones.

Interacción de esta molécula con el metabolismo

Utilizamos un modelo de Aprendizaje Profundo para predecir las interacciones de esta molécula con el metabolismo. Consulta la fuente para entender la metodología.

Reacciones que metabolizan esta molécula
Hydrolysis of carboxylic acid ester BTMR0143
Enzimas: 3.1.1.1
Hydrolysis of carboxylic acid ester BTMR0143
Enzimas: 3.1.1.1
O-Hydroxylation of monosubstituted benzene BTMR1034
Reagents

Metabolite: InChI=1S/C22H29...

O-Hydroxylation of monosubstituted benzene BTMR1034
Reagents

Metabolite: InChI=1S/C22H29...

Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring BTMR1077
Reagents

Metabolite: InChI=1S/C22H29...

N-Oxidation of aliphatic tertiary amine BTMR1100
Enzimas: CYP1A2 CYP2D6 CYP3A4
Hydroxylation of benzene on carbon para to electron donating group BTMR1047
Reagents

Metabolite: InChI=1S/C22H29...

Hydroxylation of benzene on carbon para to electron donating group BTMR1047
Reagents

Metabolite: InChI=1S/C22H29...

Hydroxylation of penultimate aliphatic secondary carbon BTMR1074
Reagents

Metabolite: InChI=1S/C22H29...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C22H29...

Hydroxylation of terminal methyl BTMR1061
Reagents

Metabolite: InChI=1S/C22H29...

Terminal desaturation BTMR1190
Reagents

Metabolite: InChI=1S/C22H27...

Terminal desaturation BTMR1190
N-Dealkylation of acyclic tertiary amine BTMR1142
Reagents

Metabolite: InChI=1S/C20H22...

N-Dealkylation of acyclic tertiary amine BTMR1142
N-Dealkylation of acyclic tertiary amine BTMR1142
Hydroxylation of penultimate aliphatic tertiary carbon BTMR1075
Reagents

Metabolite: InChI=1S/C22H29...

Aliphatic hydroxylation of carbon alpha to secondary or tertiary alkyl-N BTMR1081
Reagents

Metabolite: InChI=1S/C22H29...

N-Glucuronidation of tertiary aliphatic amine BTMR0244
Enzimas: 2.4.1.17
Reagents

Metabolite: InChI=1S/C28H37...